Carboplatin is used alone or in combination with other anticancer medications to treat various cancers, especially ovarian cancer and certain types of lung cancer. It is also used in several chemotherapy regimens for other solid tumors based on the patient’s condition and treatment plan. Carboplatin helps slow or stop the growth of cancer cells and assists in controlling the spread of cancer in the body.

Carboplatin works by damaging the DNA of cancer cells. It forms cross-links within the DNA strands, which prevents the cells from dividing and multiplying. As cancer cells are unable to repair this damage effectively, they eventually die. Since rapidly growing cancer cells are more sensitive to this effect, carboplatin helps reduce tumor growth and spread.

Carboplatin is administered as an intravenous infusion through a vein under the supervision of a healthcare professional. The dosage and frequency depend on several factors, including the patient’s body condition, kidney function, type of cancer, and treatment response. The medication is usually given in hospital or clinical settings where patients can be monitored during and after infusion.

Common side effects of carboplatin include loss of taste, diarrhea, constipation, hair loss, skin rash, itching, tiredness, weakness, breathing difficulty, inflammation of lung tissues, and tingling or numbness in the hands and feet. Some patients may also experience dizziness or prickling sensations. Serious side effects include anemia, abnormal bruising, severe allergic reactions, kidney damage, hearing problems, and increased risk of infections due to low blood cell counts. Patients should contact their healthcare provider immediately if they notice fever, unusual bleeding, severe weakness, or breathing difficulties.

Carboplatin should not be used in patients with known hypersensitivity to carboplatin or related platinum compounds. Caution is required in individuals with kidney disease, heart conditions, bone marrow suppression, or previous allergic reactions to chemotherapy drugs. Regular monitoring of blood counts, kidney function, and overall health is essential during treatment. Patients should inform their doctor about all medications, vaccinations, and medical conditions before starting therapy. Since carboplatin may affect fertility, both men and women should discuss fertility preservation options with their healthcare provider before treatment begins.

Carboplatin remains an important chemotherapy medication in the treatment of ovarian cancer, lung cancer, and several other malignancies. Its effectiveness and comparatively lower risk of certain toxicities have made it a widely used option in cancer care. However, careful monitoring and adherence to medical advice are necessary to manage side effects and achieve the best treatment outcomes. With proper support and supervision, carboplatin continues to play a valuable role in modern oncology.